Kenneth Liu

2.0k total citations · 1 hit paper
27 papers, 1.4k citations indexed

About

Kenneth Liu is a scholar working on Infectious Diseases, Neurology and Statistics and Probability. According to data from OpenAlex, Kenneth Liu has authored 27 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 5 papers in Neurology and 5 papers in Statistics and Probability. Recurrent topics in Kenneth Liu's work include Viral Infections and Outbreaks Research (6 papers), Viral Infections and Vectors (5 papers) and Statistical Methods in Clinical Trials (4 papers). Kenneth Liu is often cited by papers focused on Viral Infections and Outbreaks Research (6 papers), Viral Infections and Vectors (5 papers) and Statistical Methods in Clinical Trials (4 papers). Kenneth Liu collaborates with scholars based in United States, Canada and United Kingdom. Kenneth Liu's co-authors include Duane Snavely, Brian T. Mayers, David Sunderland, Younan Xia, W. Joseph Herring, David Michelson, Qing Li, Kristian Reich, Stuart Green and Thomas Roth and has published in prestigious journals such as The Lancet, Chemistry of Materials and Neurology.

In The Last Decade

Kenneth Liu

25 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials

2017 413 citations Kristian Reich, Kim Papp et al. The Lancet profile →

Peers

Countries citing papers authored by Kenneth Liu

Since Specialization

Citations

This map shows the geographic impact of Kenneth Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth Liu more than expected).

Fields of papers citing papers by Kenneth Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth Liu. The network helps show where Kenneth Liu may publish in the future.

Co-authorship network of co-authors of Kenneth Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth Liu. A scholar is included among the top collaborators of Kenneth Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth Liu. Kenneth Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Durability of Immunogenicity and Protection of rVSV∆G-ZEBOV-GP Vaccine in a Nonhuman Primate EBOV Challenge Model	Viruses	Sandra L. Bixler, Amy C. Shurtleff et al.	0
2	Paired C-type lectin receptors mediate specific recognition of divergent oomycete pathogens in C. elegans	Cell Reports	Kenneth Liu, Manish Grover et al.	2
3	Lessons Learned from the Development and Roll-Out of the rVSVΔG-ZEBOV-GP Zaire ebolavirus Vaccine to Inform Marburg Virus and Sudan ebolavirus Vaccines	Vaccines	Beth-Ann Coller, William Lapps et al.	6
4	Major complications of dural venous sinus stenting for idiopathic intracranial hypertension: case series and management considerations	Journal of NeuroInterventional Surgery	A Jost, Matthew R. Amans et al.	43
5	Immunogenicity, Lot Consistency, and Extended Safety of rVSVΔG-ZEBOV-GP Vaccine: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study in Healthy Adults	The Journal of Infectious Diseases	Scott A. Halperin, Rituparna Das et al.	34
6	Recommendations for the selection and treatment of patients with idiopathic intracranial hypertension for venous sinus stenting	Journal of NeuroInterventional Surgery	Kyle M Fargen, Kenneth Liu et al.	69
7	Endovascular Mechanical Thrombectomy for Acute Middle Cerebral Artery M2 Segment Occlusion: A Systematic Review	World Neurosurgery	Ching‐Jen Chen, Thomas J. Buell et al.	36
8	Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials breakdown →	The Lancet	Kristian Reich, Kim Papp et al.	413
9	Endovascular treatment for cerebral vasospasm following aneurysmal subarachnoid hemorrhage: predictors of outcome and retreatment	Journal of NeuroInterventional Surgery	Jennifer D. Sokolowski, Ching‐Jen Chen et al.	28
10	Clinical development of a recombinant Ebola vaccine in the midst of an unprecedented epidemic	Vaccine	Beth-Ann Coller, Jeffrey T. Blue et al.	35
11	Alertness and psychomotor performance effects of the histamine-3 inverse agonist MK-0249 in obstructive sleep apnea patients on continuous positive airway pressure therapy with excessive daytime sleepiness: a randomized adaptive crossover study	Sleep Medicine	W. Joseph Herring, Kenneth Liu et al.	25
12	Orexin receptor antagonism for treatment of insomnia	Neurology	W. Joseph Herring, Ellen Snyder et al.	245
13	Randomized Controlled Study of the Histamine H3 Inverse Agonist MK-0249 in Adult Attention-Deficit/Hyperactivity Disorder	The Journal of Clinical Psychiatry	W. Joseph Herring, Timothy E. Wilens et al.	25
14	Missing Data Mechanisms in a Dose-Finding Adaptive Trial	Journal of Biopharmaceutical Statistics	Kenneth Liu, Richard Entsuah	1
15	Dendritic Cell Adhesion to Cerebral Endothelium: Role of Endothelial Cell Adhesion Molecules and Their Ligands	Journal of Neuropathology & Experimental Neurology	Kenneth Liu, Katerina Dorovini‐Zis et al.	13
16	Confidence intervals for an exposure adjusted incidence rate difference with applications to clinical trials	Statistics in Medicine	G. Frank Liu, Junyuan Wang et al.	56
17	Covariate Measurement Error in the Cox Model: A Simulation Study	Communications in Statistics - Simulation and Computation	Kenneth Liu, Roslyn A. Stone et al.	2
18	Accounting for covariate measurement error in a Cox model analysis of recurrence of depression	Journal of Psychiatric Research	Kenneth Liu, Sati Mazumdar et al.	3
19	Transition (markov) models for the analysis of survival times in clinical research	Communications in Statistics - Simulation and Computation	Sati Mazumdar, Kenneth Liu et al.	0
20	Characterization of Oligonucleotide MetabolismIn Vivovia Liquid Chromatography/Electrospray Tandem Mass Spectrometry with a Quadrupole Ion Trap Mass Spectrometer	Journal of Mass Spectrometry	Richard H. Griffey, Michael J. Greig et al.	79

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact